文献速递心境障碍

重性抑郁与肥胖共病的风险变异突变图谱:下一代测序方法

Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach.
PubMed 文献 · Mol Psychiatry · 2024-05-28

该研究采用下一代测序(NGS)方法,对PISMA-ep流行病学研究中654名个体的重性抑郁(MD)和肥胖相关特定基因组区域进行测序,评估常见与罕见变异与MD和肥胖共病表型的关联。研究识别出55个独立常见变异及4个基因(PARK2、FGF21、HIST1H3D、RSRC1)的罕见变异负荷与共病表型相关,并发现代谢失调、激素信号和细胞周期调控相关生物学过程与通路显著富集。结果表明共病表型存在特异性风险变异,但受影响的基因与MD和肥胖分别共享细胞生物学过程和信号通路。

要点

  • 在654名PISMA-ep研究个体中识别出55个独立常见变异与MD和肥胖共病相关。
  • PARK2、FGF21、HIST1H3D和RSRC1四个基因的罕见变异负荷与共病表型相关。
  • 共病风险变异影响的基因富集于代谢失调、激素信号和细胞周期调控通路。

核心结论

  • MD与肥胖共病存在特异性风险变异,但其功能影响的基因与两种疾病分别共享细胞生物学过程和信号通路。

研究设计与样本

  • 对PISMA-ep流行病学研究中654名个体的MD和肥胖特定基因组区域进行下一代测序,在变异和基因水平评估与共病表型的关联。

主要发现

  • 识别出55个独立常见变异与MD和肥胖共病表型相关。
  • 发现PARK2、FGF21、HIST1H3D和RSRC1四个基因的罕见变异负荷与共病表型相关。
  • 随访分析显示与代谢失调、激素信号和细胞周期调控相关的基因集显著富集。

临床怎么用

  • 提示MD与肥胖共病具有多基因遗传基础,涉及常见与罕见变异,可为共病风险评估提供候选基因和通路线索。

局限性

  • 原文未报告样本量以外的具体统计阈值、P值或置信区间,且未涉及其他人群验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Major depression (MD) and obesity are complex genetic disorders that are frequently comorbid. However, the study of both diseases concurrently remains poorly addressed and therefore the underlying genetic mechanisms involved in this comorbidity remain largely unknown. Here we examine the contribution of common and rare variants to this comorbidity through a next-generation sequencing (NGS) approach. Specific genomic regions of interest in MD and obesity were sequenced in a group of 654 individuals from the PISMA-ep epidemiological study. We obtained variants across the entire frequency spectrum and assessed their association with comorbid MD and obesity, both at variant and gene levels. We identified 55 independent common variants and a burden of rare variants in 4 genes (PARK2, FGF21, HIST1H3D and RSRC1) associated with the comorbid phenotype. Follow-up analyses revealed significantly enriched gene-sets associated with biological processes and pathways involved in metabolic dysregulation, hormone signaling and cell cycle regulation. Our results suggest that, while risk variants specific to the comorbid phenotype have been identified, the genes functionally impacted by the risk variants share cell biological processes and signaling pathways with MD and obesity phenotypes separately. To the best of our knowledge, this is the first study involving a targeted sequencing approach toward the study of the comorbid MD and obesity. The framework presented here allowed a deep characterization of the genetics of the co-occurring MD and obesity, revealing insights into the mutational and functional profile that underlies this comorbidity and contributing to a better understanding of the relationship between these two disabling disorders.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Pérez-Gutiérrez AM, Carmona R, Loucera C, et al. Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach. Mol Psychiatry. 2024. PMID: 38806690. doi:10.1038/s41380-024-02609-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。